MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, RVP made $10,085,723 in revenue. $313,436 in net income. Net profit margin of 3.11%.

Income Overview

Revenue
$10,085,723
Net Income
$313,436
Net Profit Margin
3.11%
EPS
$0.01
Unit: Dollar
Revenue Breakdown
    • Syringes
    • Easy Point Needles
    • Easy Point Needles
    • Others
Revenue Breakdown
    • Syringes
    • Easy Point Needles
    • Blood Collection Products
    • Other Products
Revenue Breakdown
    • United States Sales
    • North And South America Sales Ex...
    • Other International Sales

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Sales, net
10,085,723 10,445,733 8,295,173 8,336,656
Product
7,572,544 9,721,614 --
Royalty
827,275 831,209 --
Total cost of sales
8,399,819 10,552,823 8,297,084 8,633,377
Gross profit (loss)
1,685,904 -107,090 -1,911 -296,721
Sales and marketing
1,583,760 1,661,743 1,601,808 1,312,220.5
Research and development
199,462 160,049 191,192 150,078
General and administrative
3,556,724 3,201,955 2,881,841 3,344,489
Total operating expenses
5,339,946 5,023,747 4,674,841 4,806,787.5
Loss from operations
-3,654,042 -5,130,837 -4,676,752 -5,103,508.5
Litigation proceeds
-1,900,000 --
Other income - tia
1,516,268 1,471,235 1,482,819 1,478,111
Unrealized gain (loss) on debt and equity securities
2,383,779 1,555,676 -7,156,513 5,568,154.5
Loss on trading debt securities
-343 ---
Interest and other income
147,663 140,526 158,946 231,180
Interest expense
20,585 22,257 23,455 30,097
Net income (loss) before income taxes
372,740 -85,657 -10,214,955 2,143,840
Provision (benefit) for income taxes
1,693 1,814 285,761 43,787.5
Net income (loss)
371,047 -87,471 -10,500,716 2,100,052.5
Preferred stock dividend requirements
57,611 57,611 57,611 57,611
Net income (loss) applicable to common shareholders
313,436 -145,082 -10,558,327 2,042,441.5
Earnings per share, basic
0.01 0 -0.35 0.075
Earnings per share, diluted
0.01 0 -0.35 0.075
Weighted average number of shares outstanding, basic
29,937,159 29,937,159 29,937,159 -14,968,579.5
Weighted average number of shares outstanding, diluted
29,937,159 29,937,159 29,937,159 -14,968,579.5
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Other Products$2,749 Easy Point Needles$145,116 Blood CollectionProducts$5,070 Syringes$195,414 Easy Point Needles$405,472 Syringes$144,326 Other Products$8,711 Easy Point Needles$3,303,166 Blood CollectionProducts$367,681 Syringes$5,508,018 Other InternationalSales$348,349 North And SouthAmerica Sales Excluding...$549,798 United States Sales$9,187,576 Interest and other income$147,663 Unrealized gain (loss) ondebt and equity...$2,383,779 Other income - tia$1,516,268 Sales, net$10,085,723 Net income (loss)before income taxes$372,740 Interest expense$20,585 Loss on trading debtsecurities-$343 Loss from operations-$3,654,042 Gross profit (loss)$1,685,904 Total cost of sales$8,399,819 Net income (loss)$371,047 Provision (benefit) forincome taxes$1,693 Total operatingexpenses$5,339,946 Royalty$827,275 Product$7,572,544 Net income (loss)applicable to common...$313,436 Preferred stock dividendrequirements$57,611 General andadministrative$3,556,724 Research and development$199,462 Sales and marketing$1,583,760

RETRACTABLE TECHNOLOGIES INC (RVP)

RETRACTABLE TECHNOLOGIES INC (RVP)